Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2017-07-04 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于进一步避免同业竞争的承诺函
Regulatory Filings Classification · 95% confidence The document is a commitment letter regarding avoidance of competition between related companies, specifically related to a share purchase transaction. It contains no financial statements, no regulatory certifications, no voting results, no management or board changes, no earnings or capital updates, and no legal proceedings. It is a formal declaration or promise related to corporate governance and business conduct but does not fit into categories like Annual Report, Audit Report, or Capital Update. It is not a report publication announcement or a certification. The document is a standalone commitment letter related to a transaction but does not announce the transaction itself or provide financial data. Given the content, it best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2017-07-04 Chinese
上市公司实际控制人关于保持上市公司独立性的承诺函
Regulatory Filings Classification · 95% confidence The document is a formal commitment letter from the actual controller of a listed company regarding maintaining the company's independence after a major asset restructuring. It includes declarations about independence in personnel, assets, business, finance, and organizational structure, as well as assurances about compliance with securities laws and absence of legal penalties. The document is short (745 characters) and is a letter of commitment rather than a financial report, announcement of voting results, or management change. It does not fit into categories like Annual Report, Interim Report, or Regulatory Filings related to financial data. It is a specific declaration related to corporate governance and control but does not detail governance structures or board changes. Given the nature and content, it best fits under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2017-07-04 Chinese
北京国枫律师事务所关于公司发行股份购买资产并募集配套资金的法律意见书
Regulatory Filings
2017-06-30 Chinese
拟发行股份收购长沙三诺健康管理有限公司部分股权而涉及该公司股东全部权益项目评估报告
Audit Report / Information Classification · 95% confidence The document is an asset appraisal report prepared by Beijing Tianjian Xingye Asset Appraisal Co., Ltd. for SanNuo Bio-sensing Co., Ltd. regarding the proposed issuance of shares to acquire part of the equity of Changsha SanNuo Health Management Co., Ltd. The report includes detailed valuation methods, asset and liability assessments, company background, and financial data as of March 31, 2017. It is a comprehensive standalone asset valuation report related to a major asset restructuring transaction. The document is not an announcement or a brief summary but a full appraisal report with detailed financial and asset information. This fits the definition of an Audit Report / Information (AR), which includes standalone audit or appraisal reports related to accounting and valuation, excluding full annual reports. Therefore, the appropriate classification is AR with high confidence.
2017-06-30 Chinese
中信证券股份有限公司关于公司重组报告书独立财务顾问核查意见表
Audit Report / Information Classification · 95% confidence The document is a detailed independent financial advisor's verification opinion form related to a major asset restructuring (重大资产重组) involving SanNuo Bio-sensing Co., Ltd. It includes extensive compliance checks against regulatory guidelines (e.g., 《重组办法》, 《26号准则》), detailed disclosures on transaction parties, asset valuations, legal opinions, financial data, and risk assessments. The content focuses on a major asset acquisition transaction, including issuance of shares and fundraising, with comprehensive due diligence and regulatory compliance documentation. This matches the characteristics of an Audit Report / Information (AR) related to a standalone audit and verification report for a major asset restructuring, rather than a full Annual Report or a simple announcement. The document length (15,000 characters) and depth of financial and legal detail confirm it is the report itself, not just an announcement. Therefore, the appropriate classification is AR (Audit Report / Information).
2017-06-30 Chinese
中信证券股份有限公司关于公司本次重组是否构成重组上市的核查意见
Audit Report / Information Classification · 95% confidence The document is a formal opinion from CITIC Securities regarding whether a specific asset restructuring transaction for SanNuo Bio-sensing Co., Ltd. constitutes a 'restructuring listing' under relevant regulatory rules. It discusses regulatory criteria, ownership percentages, and concludes that the transaction does not constitute a restructuring listing. The document is a standalone advisory opinion related to a major asset restructuring, not a full annual report, audit report, or financial statement. It is not a general regulatory filing or announcement but a specific audit/opinion report on the restructuring. Therefore, it fits best under 'Audit Report / Information (AR)' as it provides an independent financial advisory opinion on a regulatory matter related to asset restructuring.
2017-06-30 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.